Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02039674 |
|---|---|
| Brief Title: | A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021) |
| First Submitted : | January 16, 2014 |
| First Submitted that Met QC Criteria : | January 16, 2014 |
| First Posted : | January 17, 2014 (Estimate) |
| Results First Submitted : | October 27, 2017 |
| Results First Submitted that Met QC Criteria : | October 27, 2017 |
| Results First Posted : | December 2, 2017 |
| Last Update Submitted that Met QC Criteria : | October 13, 2022 |
| Last Update Posted : | November 8, 2022 |